These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 2913284

  • 1. Pharmacological profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.
    Burkard WP, Bonetti EP, Da Prada M, Martin JR, Polc P, Schaffner R, Scherschlicht R, Hefti F, Müller RK, Wyss PC.
    J Pharmacol Exp Ther; 1989 Jan; 248(1):391-9. PubMed ID: 2913284
    [Abstract] [Full Text] [Related]

  • 2. SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. I. Psychopharmacological profile in rodents.
    Worms P, Kan JP, Wermuth CG, Roncucci R, Bizière K.
    J Pharmacol Exp Ther; 1987 Jan; 240(1):241-50. PubMed ID: 3100770
    [Abstract] [Full Text] [Related]

  • 3. Hypotensive action and weak potentiation of tyramine effect by moclobemide in rats.
    Da Prada M, Burkard WP.
    Acta Psychiatr Scand Suppl; 1990 Jan; 360():106-7. PubMed ID: 2248060
    [Abstract] [Full Text] [Related]

  • 4. Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. II. Pharmacological profile.
    Caille D, Bergis OE, Fankhauser C, Gardes A, Adam R, Charieras T, Grosset A, Rovei V, Jarreau FX.
    J Pharmacol Exp Ther; 1996 Apr; 277(1):265-77. PubMed ID: 8613929
    [Abstract] [Full Text] [Related]

  • 5. In vivo characterization of T-794, a novel reversible inhibitor of monoamine oxidase-A, as an antidepressant with a wide safety margin.
    Kato M, Katayama T, Iwata H, Yamamura M, Matsuoka Y, Narita H.
    J Pharmacol Exp Ther; 1998 Mar; 284(3):983-90. PubMed ID: 9495858
    [Abstract] [Full Text] [Related]

  • 6. [Comparison of the new MAO-A inhibitors moclobemide, brofaromine and toloxatone with tranylcypromine in an animal experiment: significance for clinical practice].
    Da Prada M, Keller HH, Kettler R.
    Psychiatr Prax; 1989 Aug; 16 Suppl 1():18-24. PubMed ID: 2587673
    [Abstract] [Full Text] [Related]

  • 7. Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.
    Da Prada M, Kettler R, Keller HH, Burkard WP, Muggli-Maniglio D, Haefely WE.
    J Pharmacol Exp Ther; 1989 Jan; 248(1):400-14. PubMed ID: 2783611
    [Abstract] [Full Text] [Related]

  • 8. Pre-clinical pharmacology of moclobemide. A review of published studies.
    Burkard WP, Da Prada M, Keller HH, Kettler R, Haefely W.
    Br J Psychiatry Suppl; 1989 Oct; (6):84-8. PubMed ID: 2695131
    [Abstract] [Full Text] [Related]

  • 9. Brain microdialysis in rats: a technique to reveal competition in vivo between endogenous dopamine and moclobemide, a RIMA antidepressant.
    Colzi A, d'Agostini F, Cesura AM, Da Prada M.
    Psychopharmacology (Berl); 1992 Oct; 106 Suppl():S17-20. PubMed ID: 1546133
    [Abstract] [Full Text] [Related]

  • 10. Comparison of monoamine oxidase-A inhibition by moclobemide in vitro and ex vivo in rats.
    Kettler R, Da Prada M, Burkard WP.
    Acta Psychiatr Scand Suppl; 1990 Oct; 360():101-2. PubMed ID: 2248058
    [Abstract] [Full Text] [Related]

  • 11. Monoamine oxidase-A inhibitors and dopamine metabolism in rat caudatus: evidence that an increased cytosolic level of dopamine displaces reversible monoamine oxidase-A inhibitors in vivo.
    Colzi A, D'Agostini F, Cesura AM, Borroni E, Da Prada M.
    J Pharmacol Exp Ther; 1993 Apr; 265(1):103-11. PubMed ID: 8473998
    [Abstract] [Full Text] [Related]

  • 12. Pharmacology of moclobemide.
    Haefely W, Burkard WP, Cesura A, Colzi A, Kettler R, Lorez HP, Martin JR, Moreau JL, Richards JG, Schaffner R.
    Clin Neuropharmacol; 1993 Apr; 16 Suppl 2():S8-18. PubMed ID: 8313402
    [Abstract] [Full Text] [Related]

  • 13. Relationship between tyramine potentiation and monoamine oxidase (MAO) inhibition: comparison between moclobemide and other MAO inhibitors.
    Zimmer R.
    Acta Psychiatr Scand Suppl; 1990 Apr; 360():81-3. PubMed ID: 2248084
    [Abstract] [Full Text] [Related]

  • 14. Effect of moclobemide on rat brain monoamine oxidase A and B: comparison with harmaline and clorgyline.
    Gerardy J.
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul; 18(4):793-802. PubMed ID: 7938567
    [Abstract] [Full Text] [Related]

  • 15. Some basic aspects of reversible inhibitors of monoamine oxidase-A.
    Da Prada M, Kettler R, Burkard WP, Lorez HP, Haefely W.
    Acta Psychiatr Scand Suppl; 1990 Jul; 360():7-12. PubMed ID: 2248079
    [Abstract] [Full Text] [Related]

  • 16. Interaction of moclobemide and tricyclic antidepressants with the tyramine pressor effect in rats.
    Burkard W, d'Agostini F, Kettler R, Da Prada M.
    Psychopharmacology (Berl); 1992 Jul; 106 Suppl():S35-6. PubMed ID: 1546137
    [Abstract] [Full Text] [Related]

  • 17. SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. II. Biochemical characterization of monoamine oxidase inhibition.
    Kan JP, Steinberg R, Mouget-Goniot C, Worms P, Bizière K.
    J Pharmacol Exp Ther; 1987 Jan; 240(1):251-8. PubMed ID: 3100771
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.